Elme Communities Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated August 11, 2026, reports the completion of the sale of Elme Bethesda, a 193-unit multifamily community in Bethesda, Maryland. The transaction was executed by Elme Bethesda Owner LLC, a wholly owned subsidiary of Elme Communities. The filing also provides unaudited pro forma financial information reflecting this disposition and prior significant transactions, including the November 2025 sale of the Cortland Portfolio and the subsequent liquidation plan approved by shareholders.
Key Financial Metrics
- Sale Proceeds: The Elme Bethesda property was sold for a purchase price of $58.0 million, subject to customary prorations and adjustments.
- Net Cash Proceeds: Approximately $2.76 million in net cash proceeds were retained after closing adjustments and debt repayment.
- Debt Repayment: Approximately $52.45 million of the gross proceeds was used to repay a portion of the Company's $520.0 million senior secured Term Loan.
- Pro Forma Net Assets (Liquidation Basis): As of June 30, 2026, pro forma net assets in liquidation are reported at $167.7 million following the Bethesda disposition.
- Pro Forma Net Loss (Going Concern Basis): For the ten months ended October 31, 2025, the pro forma net loss is $232.1 million, reflecting the elimination of the Cortland Portfolio, debt prepayment costs, and the Bethesda disposition.
Material Changes and Transactions
The primary material change is the August 11, 2026, closing of the Bethesda sale. This follows a series of major asset dispositions:
- Cortland Portfolio Sale: Completed on November 12, 2025, for an aggregate contract price of $1.606 billion.
- Debt Restructuring: In connection with the November 2025 sale, the Company repaid all existing indebtedness (Revolver, Term Loan, NPA Notes, and Senior Notes) and entered into a new $520.0 million Term Loan secured by the remaining 10 properties.
- Subsequent Sales: As of June 30, 2026, the Company had sold six of its remaining properties (five multifamily and one office) for aggregate gross proceeds of approximately $294 million.
- Liquidation Status: The Company is operating under a Plan of Sale and Liquidation approved on October 30, 2025. Financial statements are presented on a liquidation basis for periods after the portfolio sale.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance or management commentary regarding future operational performance, as the Company is in the process of liquidation. The pro forma financial information is explicitly stated to be not indicative of actual future results. Key risks and contingencies include:
- Liquidation Basis: Financial statements reflect the liquidation basis of accounting, where assets are measured at estimated net realizable value and liabilities at estimated settlement amounts.
- Pro Forma Limitations: The pro forma data assumes the Bethesda disposition occurred on various prior dates (e.g., January 1, 2025, or June 30, 2026) and does not represent actual historical results for those periods.
- Interest Rate Sensitivity: The new Term Loan carries a variable interest rate (SOFR + 2.25%). A 0.125% variance in interest rates would impact income by approximately $541,700 for the ten-month period ended October 31, 2025.
Investor Verification Checklist
- Verify the final closing statement for the Elme Bethesda sale to confirm the exact net proceeds after all prorations and adjustments.
- Review the remaining property portfolio to assess the timeline and expected proceeds for the remaining unsold assets under the liquidation plan.
- Confirm the current outstanding balance of the $520.0 million Term Loan and the schedule for future debt repayments from remaining asset sales.
- Examine the "Liabilities for estimated costs in excess of estimated receipts during liquidation" line item ($34.1 million pro forma) to understand projected liquidation expenses.
- Check subsequent filings for updates on the sale of the remaining properties and the timing of final liquidating distributions to shareholders.